These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6237623)

  • 1. Low-dose captopril for the treatment of mild to moderate hypertension. I. Results of a 14-week trial. Veterans Administration Cooperative Study Group on Antihypertensive Agents.
    Arch Intern Med; 1984 Oct; 144(10):1947-53. PubMed ID: 6237623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of captopril (SQ 14225) with hydrochlorothiazide in the treatment of essential hypertension.
    Aberg H; Frithz G; Mörlin C
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):368-71. PubMed ID: 7030977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of captopril and hydrochlorothiazide alone and in combination in mild to moderate essential hypertension.
    Weinberger MH
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):127S-131S. PubMed ID: 6753893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing dosages of captopril and hydrochlorothiazide in the treatment of hypertension: long-term effects metabolic values and intracellular electrolytes.
    Costa FV; Borghi C; Boschi S; Ambrosioni E
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S70-6. PubMed ID: 2580180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Captopril, an orally active converting enzyme inhibitor, in the treatment of primary hypertension. A controlled long-term study with reference to initial plasma renin activity.
    Karlberg BE; Asplund J; Nilsson OR; Wettre S; Ohman KP
    Acta Med Scand; 1981; 209(4):245-52. PubMed ID: 7015795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Captopril and hydrochlorothiazide in the fixed combination multicenter trial.
    Lederle RM
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S63-9. PubMed ID: 2580179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide.
    Veterans Administration Co-Operative Study Group on Antihypertensive Agents
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):97S-101S. PubMed ID: 6753911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Captopril or atenolol in essential hypertension.
    Andrén L; Svensson A; Hansson L
    Acta Med Scand Suppl; 1983; 677():115-8. PubMed ID: 6367371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose captopril: its use in mild to moderate hypertension unresponsive to diuretic treatment.
    Vlasses PH; Rotmensch HH; Swanson BN; Mojaverian P; Ferguson RK
    Arch Intern Med; 1982 Jun; 142(6):1098-101. PubMed ID: 6284081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of captopril and atenolol in essential hypertension.
    Andrén L; Karlberg BE; Svensson A; Ohman P; Nilsson OR; Hansson L
    Acta Med Scand; 1985; 217(2):155-60. PubMed ID: 3887847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose captopril for the treatment of mild to moderate hypertension.
    Hypertension; 1983; 5(5 Pt 2):III139-44. PubMed ID: 6354929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of antihypertensive effect of low-dose captopril in mild to moderate hypertension.
    Clin Pharmacol Ther; 1984 Sep; 36(3):307-14. PubMed ID: 6380879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo-controlled comparison of captopril, metoprolol, and hydrochlorothiazide therapy in non-insulin-dependent diabetic patients with primary hypertension.
    Gall MA; Rossing P; Skøtt P; Hommel E; Mathiesen ER; Gerdes LU; Lauritzen M; Vølund A; Faergeman O; Beck-Nielsen H
    Am J Hypertens; 1992 May; 5(5 Pt 1):257-65. PubMed ID: 1581012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once vs twice daily administration of a fixed combination of captopril plus hydrochlorothiazide in essential hypertension: a double-blind crossover study in known responders to a standard combination.
    Lacourcière Y; Poirier L; Provencher P; Guivarc'h PH
    Br J Clin Pharmacol; 1991 Jul; 32(1):115-9. PubMed ID: 1888630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An open comparative study of captopril + hydrochlorothiazide versus chlorthalidone for the treatment of mild and moderate primary hypertension].
    Franco RJ; Sampaio M; Balbi AL; Martin LC; Luna RL
    Arq Bras Cardiol; 1992 Nov; 59(5):423-7. PubMed ID: 1340743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antihypertensive effects of captopril and propranolol in essential hypertension.
    Huang CM; del Greco F; Quintanilla A; Molteni A
    JAMA; 1981 Feb; 245(5):478-82. PubMed ID: 7005474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crossover comparison of captopril and propranolol as step 2 agents in hypertension.
    Oren A; Rotmensch HH; Vlasses PH; Riley LJ; Tadros SS; Koplin JR; Ferguson RK
    Am Heart J; 1985 Mar; 109(3 Pt 1):554-7. PubMed ID: 3883729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age and antihypertensive drugs (hydrochlorothiazide, bendroflumethiazide, nadolol and captopril).
    Freis ED
    Am J Cardiol; 1988 Jan; 61(1):117-21. PubMed ID: 3276117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose captopril in mild to moderate geriatric hypertension.
    Tuck ML; Katz LA; Kirkendall WM; Koeppe PR; Ruoff GE; Sapir DG
    J Am Geriatr Soc; 1986 Oct; 34(10):693-6. PubMed ID: 3531295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term experience of captopril in the treatment of primary (essential) hypertension.
    Karlberg BE; Asplund J; Wettre S; Ohman KP; Nilsson OR
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):133S-137S. PubMed ID: 6753894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.